RE: AEX and HE1 - forgot SCIR29 Dec 2020 23:52
Funding is an issue. You say that in terms of obtaining, but funding wont be directly targeted at the asset. There are general costs to keep things going so timing also comes in, as seen for quite sometime now. That timing, if prolonged, means cost to shareholders. IMO they need to sell ruvuma asap and look for shorter term gains. I think that's obvious and the lack of action is quite worrying in terms of offers available.